COL10A1 and metabolic dysfunction-associated steatohepatitis: This interspecies consistency not only reinforces the biological plausibility of TPPP3/COL10A1 as core fibrogenic effectors but also positions them as translatable biomarkers for stratifying NASH progression or evaluating antifibrotic therapies.